Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04096235 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Use of the Neotech RAM Nasal Cannula for CPAP and Bi-PAP Application in Infants 28-42 Weeks Gestation in a Neonatal Intensive Care Unit (NICU)
A NA study, sponsored by Englewood Hospital and Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04096235 is a NA study that was terminated before completion, run by Englewood Hospital and Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT04096235, a NA study, was terminated before completion, sponsored by Englewood Hospital and Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study will explore the RAM Nasal Cannula as a means of providing CPAP and Bi-PAP to infants 28-42 weeks gestation to prevent nasal septal erosion.
Interventions
- OTHER RAM Nasal Cannula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-10-18 |
| Est. Completion | 2021-07-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04096235
The ClinicalTrials.gov registry entry for NCT04096235 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Englewood Hospital and Medical Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RAM Nasal Cannula is the first listed.
NCT04096235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04096235 about?
NCT04096235 is a clinical study titled "A Study to Evaluate the Use of the Neotech RAM Nasal Cannula for CPAP and Bi-PAP Application in Infants 28-42 Weeks Gestation in a Neonatal Intensive Care Unit (NICU)". This study will explore the RAM Nasal Cannula as a means of providing CPAP and Bi-PAP to infants 28-42 weeks gestation to prevent nasal septal erosion.
What is the current status of trial NCT04096235?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2019-10-18. Estimated completion is 2021-07-08.
What interventions are being tested in trial NCT04096235?
The interventions under investigation include: RAM Nasal Cannula (OTHER).
Who is sponsoring clinical trial NCT04096235?
This trial is sponsored by Englewood Hospital and Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.